View in EDS HTML Full Text PDF Full Text

Fluoxetine disrupts cholesterol metabolism in endothelial cells via SREBP2 activation.

Saved in:
Bibliographic Details
Title: Fluoxetine disrupts cholesterol metabolism in endothelial cells via SREBP2 activation.
Authors: Oliveira F; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany.; Faculty of Medicine, University of Leipzig, Leipzig, Germany., Papa C; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany., Hagemann T; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany., Schipper R; Department of Medicine Solna, Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden., Geier F; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany., Röxe T; Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany., Zulfqar F; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany., Prönnecke C; Department of Technical Biogeochemistry, Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany., Schmidt L; Department of Technical Biogeochemistry, Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany., Stryhanyuk H; Department of Technical Biogeochemistry, Helmholtz Centre for Environmental Research - UFZ, Leipzig, Germany., Hoffmann A; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany., Kyselova A; European Center for Angioscience, Department of Vascular Dysfunction, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Karantanou C; European Center for Angioscience, Department of Vascular Dysfunction, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Buckley Y; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany., Farhan MA; Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany., Rodríguez-Aguilera JR; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany., Ambreen S; Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany., Yao H; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany., Arif A; Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany., Martin HNG; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany., Ebert T; Medical Department III - Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, Leipzig, Germany., Klöting N; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany., Blüher M; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany.; Medical Department III - Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, Leipzig, Germany., Shahzad K; Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany., Boeckel JN; Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Leipzig, Germany., Hagberg CE; Department of Medicine Solna, Division of Cardiovascular Medicine, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden., Chakaroun R; Medical Department III - Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, Leipzig, Germany.; Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden., Bibli SI; European Center for Angioscience, Department of Vascular Dysfunction, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; German Centre for Cardiovascular Research (DZHK), Berlin, Germany.; Helmholtz-Institute for Translational AngioCardioScience (HI-TAC) of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Heidelberg University, Heidelberg, Germany., Sheikh BN; Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich, Leipzig, Germany. bilal.sheikh@helmholtz-munich.de.; Faculty of Medicine, University of Leipzig, Leipzig, Germany. bilal.sheikh@helmholtz-munich.de.; German Centre for Cardiovascular Research (DZHK), Berlin, Germany. bilal.sheikh@helmholtz-munich.de.; German Centre for Diabetes Research (DZD), Neuherberg, Germany. bilal.sheikh@helmholtz-munich.de.
Source: Translational psychiatry [Transl Psychiatry] 2026 Jun 23; Vol. 16 (1). Date of Electronic Publication: 2026 Jun 23.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101562664 Publication Model: Electronic Cited Medium: Internet ISSN: 2158-3188 (Electronic) Linking ISSN: 21583188 NLM ISO Abbreviation: Transl Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2158-3188
DOI:10.1038/s41398-026-04197-x